Industry
Home Infusion Demand Grows Amid Reimbursement and Site-of-Care Restrictions
Demand for home infusion services is accelerating as payers and health systems move patients to lower-cost settings and expedite hospital discharges. Providers face operational obstacles including site-of-care restrictions that limit where services can be rendered and delivered, inconsistent contracting standards across payers, and reimbursement constraints that complicate scaling these programs. The trend affects Medicaid managed care plans seeking cost savings through alternate site strategies and providers adjusting care delivery models to accommodate payer preferences for home-based treatment.
Why it mattersMedicaid managed care plans increasingly rely on home infusion to reduce inpatient costs and meet value-based care targets, but inconsistent contracting and site-of-care payment rules create network adequacy and access risks.